Hemostats are agents used to compress or treat bleeding vessels in order to arrest hemorrhage. These products may reduce operating room time and decrease the number of blood transfusions required in surgical procedures. Hemostatic gents are available in various forms including pads, sponges, liquids, and powders.
For industry structure analysis, the Hemostats Industry is concentrate. The top five producers account for about 56.58% of the revenue market. Regionally, USA e is the biggest consumption area of Hemostats, also the leader in the whole Hemostats.
Major manufacturers in the market are Ethicon, Inc., Pfizer, Inc., Baxter International Inc., C. R. Bard and The Medicines Company.
To grab more market, the little companies have to expand the technology, capital investment and brand influence. To meet the challenge of the little companies and keep their leading stage, leading companies need to increase the technology innovation and speed up the product upgrading. In the future, Hemostats market will be a market of fierce competition.
In order to feed the changing technical requirements, Hemostats manufacturers need to pay attention to the technical innovation. In future, Thrombin-Based Hemostats will be the technology trends of Hemostats.
According to this study, over the next five years the Hemostats market will register a 6.0% CAGR in terms of revenue, the global market size will reach USD 3070 million by 2024, from USD 2160 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Hemostats business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Hemostats market by product type, application, key manufacturers and key regions and countries.
This study considers the Hemostats value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Thrombin-Based Hemostats
Oxidized Regenerated Cellulose Based Hemostats
Combination Hemostats
Gelatin Based Hemostats
Collagen Based Hemostats
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Prehospital Treatment
Hospital Treatment
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Ethicon
Pfizer
Baxter International Inc.
C. R. Bard
The Medicines Company
Anika Therapeutics
Advanced Medical Solutions
Integra LifeSciences Corporation
B Braun Melsungen AG
Gelita Medical GmbH
Equimedical
Vascular Solutions
Marine Polymer Technologies
Z-Medica, LLC
CryoLife
BioCer Entwicklungs-GmbH.
Biom'Up SAS
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Hemostats consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Hemostats market by identifying its various subsegments.
Focuses on the key global Hemostats manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Hemostats with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Hemostats submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
